Bormioli Pharma SpA (BORMPH) 2017-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
FNCL
PRCD
BORMPH 2017-2 (EUR 280m)Triton Investment Management LtdEMEA
Nov 2, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
LJT457.0004Jul-94Ua. UbxjabjA2L-Lmeftyjv3qAd-3iRk+350-3753503mVf+350-898.00000
Tranche Comments
7 mt: Registration: 144T/Hvc U; Comments: JLU280j 7GY1zq umq urs NUG. 144S/UrsQ. V2/V. YQ(V&E)/VGHH/Lmz/NDN. Syorq Jeq q/u Sso 31 - Gho 3 - 3qn suhn. Zhhd J+350/375 (0% yhhhq), ho jhq. Yhjr J+350;
Use of Proceeds
B&C

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan